Eli Lilly and Company announced new data regarding the mechanism of action of basal insulin peglispro (BIL). When BIL and insulin glargine were each administered to achieve complete suppression of ...

Continuous subcutaneous insulin infusion (CSII) has become an indispensable modality in the management of type 1 diabetes. This therapy employs an insulin pump to deliver both basal and bolus doses, ...

IN a consideration of the mode of action of insulin it is of some importance to know the equivalent relationship between the amounts of hormone and dextrose, that is, the number of molecules of ...

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes. By Gina Kolata A single infusion ...